Welcome to another posting of ‘Industry Insight with Chester,’ a periodic round-up of news and views from around the Pharma and biopharma industries compiled by Chester Solack, Business Analyst at SAFC in Lenexa, Kansas.
Archive for the ‘CMOs’ Category
Industry Insight with Chester: A Collection of Current Industry Updates
Friday, May 18th, 2012Contract Pharma Outsourcing Survey 2012
Tuesday, May 15th, 2012Contract Pharma recently released their annual Outsourcing Survey where the publication takes time to poll players in the pharma industry on hot button outsourcing topics. The survey is broken out by size of company, specialty of company and title of the responders and as a whole, it offers exceptional insight into the current landscape of outsourcing and upcoming trends. The full report can be found by clicking here.
Supply Chain Security Highligted at the Annual TIDES Event in Las Vegas
Thursday, May 10th, 2012SAFC will be onsite from May 20-23, 2012 at the Mandalay Bay in Las Vegas, Nevada for the annual TIDES Event hosted by IBC Life Sciences. We hope that you may be able to join SAFC at booth #206 and would also like to extend an invitation to a presentation at 4 p.m. on Tuesday, May 22, 2012. During this time, Senior Manufacturing Manager, Andreas Wolter will participate as a panel member for a presentation titled “The Oligo Supply Chain: How Strong is the Weakest Link?” which will focus on new developments and solutions for supply chain security.
To set up a meeting with an SAFC representative, or for more information regarding SAFC’s nucleic acid solutions, contact us here. We also invite you to fill out this survey to receive a 20% discount code on your attendee registration.
We look forward to seeing you there!
A Deeper Look Into the Bulk Pharmaceutical Task Force
Wednesday, May 2nd, 2012In April, SAFC Live highlighted Patty Benson’s participation at the ICH Q3D Metal Impurities Workshop in Bethesda, Maryland as part of a panel presentation where she provided an API supplier’s perspective. As a follow up to that piece, we sat down with Patty to discuss the Bulk Pharmaceutical Task Force (BPTF) in more detail. Here, she offers insight into who the BPTF is, what they do, what they are currently working on and what the future holds. The full story follows:
SAFC Reports Record Q1 Earnings
Friday, April 27th, 2012This week, SAFC announced record Q1 earnings. As noted by Sigma Aldrich President and CEO, Rakesh Sachdev, in the Q1 earnings call the results were contributed to strategic initiatives and acquisitions. He noted that, “Aided by the acquisition of BioReliance, SAFC sales of $197 million achieved a new quarterly high.” The growth was also contributed to an ever evolving global market that SAFC has committed to moving and changing with. Sachdev continued, “In addition to pharma outsourcing, the emerging markets continue to benefit from a strategic emphasis that the countries in these markets place on Life Science research.”
Q1 serves as a lead into even greater expectations for SAFC’s continued organic growth throughout 2012 and beyond. Sachdev provided further detail about these expectations, “With 1% organic growth for SAFC in Q1, we continue to expect sales growth to achieve low- to mid-single-digit organic growth in the second quarter as it is impacted by the same tougher comps related to the pre-buy in the SAFC Bioscience business in 2011, a slightly weaker LED market and capacity constraints in Hitech, which will be progressively alleviated beginning in the second quarter as our new Taiwan plant comes online.”
For the full Q1 2012 earnings report, please click here.
A Deeper Look Into the New CHOZN® Platform System for Recombinant Protein Production
Friday, April 13th, 2012On Wednesday, April 11th, SAFC announced the launch of the CHOZN cell platform system for biopharma producers to create and scale up high producing clones more quickly and easily. Here, SAFC Live speaks to Kevin Kayser, Associate Director of Cell Sciences and Development at SAFC, about why the platform was developed, and what it can do.
BREAKING NEWS: SAFC Launches CHOZN® Platform System to Accelerate Recombinant Protein Drug Development
Wednesday, April 11th, 2012Today, SAFC announced the launch of the CHOZN® Platform System to accelerate recombinant protein drug development. The new platform allows faster and simpler selection of high producing clones for use in recombinant protein drugs, as well as facilitating a more efficient scale-up process. The full press release is available below.
